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nlNormal sleep requires the astrocyte brain-type fatty
acid binding protein FABP7
Jason R. Gerstner,1,2* Isaac J. Perron,3,4 Samantha M. Riedy,1,2 Takeo Yoshikawa,5
Hiroshi Kadotani,6 Yuji Owada,7 Hans P. A. Van Dongen,1,2 Raymond J. Galante,3
Kaitlin Dickinson,8 Jerry C. P. Yin,8 Allan I. Pack,3† Marcos G. Frank1,2†
Sleep is found widely in the animal kingdom. Despite this, few conserved molecular pathways that govern sleep
across phyla have been described. The mammalian brain-type fatty acid binding protein (Fabp7) is expressed in
astrocytes, and its mRNA oscillates in tandem with the sleep-wake cycle. However, the role of FABP7 in regulating
sleep remains poorly understood. We found that the missense mutation FABP7.T61M is associated with fragmented
sleep in humans. This phenotype was recapitulated in mice and fruitflies bearing similar mutations: Fabp7-deficient
mice and transgenic flies that express the FABP7.T61Mmissense mutation in astrocytes also show fragmented sleep.
These results provide novel evidence for a distinct molecular pathway linking lipid-signaling cascades within astro-
cytes in sleep regulation among phylogenetically disparate species. oa o
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 INTRODUCTION
Sleep occurs throughout the animal kingdom, suggesting that it serves
an important and conserved function (1). Phylogenetically conserved
mechanisms governing sleep across species are known to include neu-
rotransmitters, cytokines, adenosine 5′-triphosphate, and genetic factors
(2–4). The influence of these factors on sleep regulation has traditionally
been considered in the context of neuronal function. More recently, as-
trocytes, a type of glial cell in the brain, have been recognized as an
integral player in sleep regulatory processes (5–7). However, the role
of an astrocyte gene in regulating phylogenetically conserved sleep be-
havior across multiple species has not been reported.
Fatty acid binding proteins (FABPs) comprise a family of small
(~15 kDa) hydrophobic ligand binding carriers with high affinity
for long-chain fatty acids, which they transport within the cell. FABPs
are associated with metabolic, inflammatory, and energy homeostasis
pathways (8, 9) and have been implicated in cognitive disorders (10).
FABPs have a conserved fingerprint (PRINTS pattern FATTYACIDBP;
PR00178) defined by three motifs that form b strands, along with func-
tional domains, which include a nuclear localization signal (NLS), a nu-
clear export signal (NES), and a hormone-sensitive lipase (HSL) binding
site (Fig. 1). Three FABPs are expressed in the adult mammalian central
nervous system: Fabp3 (H-Fabp), Fabp5 (E-Fabp), and Fabp7 (B-Fabp).
Fabp3 is predominantly expressed in neurons, Fabp5 is expressed in
multiple cell types, including both neurons and glia, and Fabp7 is
expressed in astrocytes and neural progenitors (8).
We previously characterized diurnal Fabp7mRNA expression through-
out the mouse brain (11, 12) and showed that transgenic flies overex-
pressing either murine Fabp7 or the Drosophila melanogaster homologdFabp have increased total sleep time (13). Although these observations
suggest that Fabp7 influences sleep, a specific role for Fabp7 in reg-
ulating sleep across phylogenetically disparate species has not been
determined.
Here, we determined the effects of the mutated FABP7 gene on sleep
in humans, mice, and fruitflies. We identified a single-nucleotide poly-
morphism (SNP) of the FABP7 gene (rs2279381) that is associated with
fragmented sleep in humans. We also showed that the human frag-
mented sleep phenotype is recapitulated in Fabp7-deficient mice. Last,
astrocyte-specific expression of the human FABP7mutant generated a
similar fragmented sleep phenotype compared to the human FABP7
wild type (WT) in transgenic fruitflies. These results provide the first
documented evidence for an astrocyte-enriched gene regulating
complex behavior across multiple species.RESULTS
To determine whether allelic variants in FABP7 are associated with
sleep disruption in humans, we examined a group of 294 adult male
Japanese subjects who underwent 7 days of actigraphy and analysis of
DNA for polymorphisms. In 29 of the 294 subjects, we found the
presence of the natural variant C to T in the DNA sequence of FABP7
that encodes a missense threonine-to-methionine mutation at position
61 (T61M) of the FABP7 protein (Fig. 1). The threonine at position 61
of FABP7 (T61) is conserved in mammals and is a residue that inter-
acts with the omega-3 fatty acid docosahexaenoic acid (DHA), a long-
chain polyunsaturated fatty acid known to have high affinity for Fabp7
(14). T61 is also in close proximity to a highly conserved region contain-
ing a phenylalanine site (F57) known to regulate the NLS in FABPs (15).
The NLS is not in the primary sequence, but upon binding with ac-
tivating ligands, the NLS is revealed in the three-dimensional (3D)
structure of the protein, located in the helix-loop-helix region (Fig. 1).
Upon DHA binding, the NLS of WT FABP7 is normally formed
following a 3D shift of the K21 site (HSL-interacting), which is affected
by the T61M mutation (Fig. 1), and predicted to cause abnormal func-
tion by the PolyPhen-2 software. Total sleep was similar between carriers
and noncarriers [339.3 ± 6.6 min (FABP7 T61M) versus 336.8 ± 2.9 min
(FABP7 WT), not significant (n.s.)], whereas the average length of an
episode (or “bout”) of sleep (see Materials and Methods) in subjects
carrying the FABP7 T61Mmutation was shorter compared with normal1 of 7
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 subjects (Fig. 2A), and the frequency of sleep bouts was higher in mu-
tation carriers compared with noncarriers (Fig. 2B). Wake after sleep
onset [52.4 ± 2.9 min (FABP7 T61M) versus 48.2 ± 1.2 min (FABP7
WT), n.s.] and the average wake bout length (Fig. 2C) were not found
to be different between carriers and noncarriers; however, the frequen-
cy of wake bouts was higher in carriers compared to noncarriers (Fig.
2D). Carriers did not significantly vary in age, body mass index, or
sleepiness compared to noncarriers (table S1). Carriers also reported
no significant differences in overall health (eight of the eight scaled
scores from the Short Form 36 Health Survey; table S2). Compared
to noncarriers, carriers showed a significant increase in Zung’s Self-
Rating Depression Scale (table S2) but were still within the normal
range of nondepression (16). Collectively, these results indicated that
the FABP7 T61M mutation resulted in abnormally fragmented sleep
without any observed comorbidities.
We found a similar sleep phenotype in Fabp7 knockout (KO)
mice. Fabp7 KO mice had shorter non–rapid eye movement (NREM)
bout durations and more NREM bouts during their active phase (dark
period) compared to control WT littermate mice (Fig. 3, A and B).
There were no differences in REM bout duration during either the
light or the dark period (Fig. 3C). However, REM bout frequency
was increased in the dark period in Fabp7 KO mice compared to
WT (Fig. 3D). Fabp7 KO mice also had shorter wake bout durations
and more wake bouts during the dark period compared to control WT
littermate mice (Fig. 3, E and F). Analysis of wake bout distribution
across varying bout lengths showed that Fabp7 KO mice had a signif-
icant increase in the number of shorter wake bouts compared to WT
(Fig. 3G). Fabp7 KOmice also had a significant increase in the number
of state transitions compared to WT (Fig. 3H). Differences in remain-
ing sleep architecture between Fabp7 KO and WT mice were not ob-
served (fig. S1). To exclude the possibility that the sleep fragmentation
phenotype is due to hyperactivity, we also examined running wheel
revolutions between Fabp7 KO and WT mice and did not observe
any differences (fig. S2). Collectively, these data suggest that, similar
to carriers of the human FABP7 missense mutation, Fabp7-deficient
mice show increased sleep fragmentation compared to WT controls.
We then determined whether Fabp7 KO also influences sleep need
by examining sleep changes during both baseline and after sleepFig. 1. Effects of a human FABP7 point mutation on FABP7 protein structure. The FABP7 protein sequence contains three highly conserved motifs consisting of b sheets
across FABP types. T61 is flankedbyNLS andNES regions. T61 is located adjacent to F57, a site important for generating theNLSwith the K21domain that interactswithHSL. Upon
ligand binding (that is, with DHA), a 3D conformational shift in the protein generates an NLS with K21 in WT FABP7, which is disrupted by the T61M variant, affecting nuclear
localization and lipid-targeted transcriptional cascades.Fig. 2. The FABP7 T61Mmissensemutation is associated with fragmented sleep
in humans. (A and B) Sleep bout duration (A) was significantly decreased and sleep
bout frequency (B) was significantly increased in T61M carriers (n = 29) versus noncar-
riers (n = 265). (C) Wake bout duration was not affected by the T61M variant. (D) Wake
bout frequency was significantly higher in T61M carriers versus noncarriers. *P < 0.05,
**P < 0.01. Data are from the 7-day average of 24-hour bins. Error bars represent SEM.2 of 7
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 Fig. 3. The human FABP7 point mutation phenotype is recapitulated in Fabp7 KO mice, which also showed sleep fragmentation. (A) NREM bout duration was
significantly lower in Fabp7 KO mice (n = 8) compared to WT littermates (n = 7) during the dark phase [Zeitgeber time (ZT) 12 to ZT 24] but was unaffected during the
light phase (ZT 0 to ZT 12). (B) NREM bout frequency was significantly higher in Fabp7 KO mice compared to WT littermates during the dark phase (ZT 12 to ZT 24) but
was unaffected during the light phase (ZT 0 to ZT 12). (C) REM bout duration was not affected in Fabp7 KO mice compared to WT mice. (D) REM bout frequency was
significantly higher in Fabp7 KO mice compared to WT littermates during the dark phase (ZT 12 to ZT 24). (E) Wake bout duration was significantly lower in Fabp7 KO
mice compared to WT during the dark phase (ZT 12 to ZT 24) but was unaffected during the light phase (ZT 0 to ZT 12). (F) Wake bout frequency was significantly
higher in Fabp7 KO mice compared to WT during the dark phase (ZT 12 to ZT 24) but was unaffected during the light phase (ZT 0 to ZT 12). (G) The number of short
wake bouts was increased in Fabp7 KO mice compared to WT (ZT 12 to ZT 24). (H) The number of NREM to wake (N→W), wake to NREM (W→N), NREM to REM (N→R),
and REM to wake (R→W) transitions was increased in Fabp7 KO mice compared to WT mice (ZT 12 to ZT 24). *P < 0.05, **P < 0.01. Error bars represent SEM.Gerstner et al., Sci. Adv. 2017;3 : e1602663 5 April 2017 3 of 7
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 deprivation conditions. These metrics included NREM electroencepha-
lography (EEG) delta power (0.5 to 4.0 Hz) and REM sleep time.
NREM delta power increases with sleep pressure, declines following
subsequent sleep, and is under genetic control (17). In mice, REM
sleep time also increases in a compensatory manner following total
sleep deprivation (17). Fabp7 deficiency did not affect the normal dis-
sipation of NREM delta power during the baseline light period or
following 6 hours of sleep deprivation [repeated-measures analysis
of variance (ANOVA), factors for genotype, condition, and time; all
genotype effects/interactions P >0.05, data not shown]. However, there
was a significant increase in REM sleep during the subsequent dark
period (ZT 12 to ZT 24) in Fabp7 KO versus WT mice (fig. S3F). The
increase in REM rebound in the KO suggests that Fabp7 influences
REM sleep regulation.
We then explored whether a role for Fabp7 in sleep was conserved
across phyla by examining D. melanogaster. Previously, we showed that
murine Fabp7 or dFabp pan-cellular overexpression in Drosophila in-
creases sleep (13), suggesting that FABP influences on sleep are con-
served across species. To test whether an astrocyte-specific functional
Fabp7 is required for normal sleep, we generated transgenic flies that
express either FABP7WT (FABP7.WT) or FABP7 T61M (FABP7.T61M)
using the UAS (upstream activation sequence)–GAL4 binary system (18).
When crossed with flies that carry the Alrm-GAL4 driver (19), UAS-
FABP7.WT or UAS-FABP7.T61M is expressed specifically in Drosophila
astrocytes. Transgenic flies that express FABP7.T61M under astrocyte con-
trol show decreased total sleep time over 24 hours [1076.0 ± 21.9 min
(FABP7.T61M) versus 1228.5 ± 15.1 min (FABP7.WT), P < 0.001],
but this effect was restricted to differences in daytime, whereas no dif-
ferences were observed during night (Fig. 4, A and B). Similar to hu-
man FABP7 T61M carriers, the effects of FABP7.T61M show increasedGerstner et al., Sci. Adv. 2017;3 : e1602663 5 April 2017sleep fragmentation compared to FABP7.WT flies. The FABP7.T61M
flies had shorter bout durations, a reduction in the maximum sleep
bout duration, and an increase in the frequency of sleep bouts. Analo-
gous to human FABP7 T61M carriers and Fabp7 KO mice, an increase
in frequency of wake bouts was observed in FABP7.T61M flies com-
pared to FABP7.WT flies (fig. S4). These effects were recapitulated in
male flies (figs. S5 and S6). To control for potential developmental
effects, we measured sleep in adult flies with conditionally expressed
FABP7.T61M or FABP7.WT in glial cells using the GeneSwitch System.
The glial-GeneSwitch works by expressing a progesterone receptor–
fused Gal4 downstream of a glial driver (20). Upon RU486 treatment,
conditional expression of UAS-FABP7.T61M or FABP7.WT is induced.
We observed a significant reduction in nighttime sleep, night bout du-
ration, and nighttime maximum bout duration and an increase in the
number of night sleep bouts in UAS-FABP7.T61M flies when treated
with RU486 compared to FABP7.WT flies (fig. S7). Together, these
results indicate that the FABP7.T61M mutation expressed in astrocytes
causes sleep fragmentation in fruitflies. In conjunction with our findings
in humans and mice, they suggest that Fabp7 has a conserved role in
sleep across diverse animal phyla.DISCUSSION
The current study demonstrates that an astrocytic-associated gene in-
fluences sleep in humans, mice, and flies. Our findings are generally
consistent with a previous study that found that SNP mutations in the
human Dec2 gene are associated with disrupted sleep (21, 22) in hu-
mans, mice, and flies (21). The pan-neuronal driver elav-Gal4 was
used to express the Dec2 gene mutation in flies, but this driver does
not rule out the potential effects of astrocytic Dec2. Dec2 gene expres-
sion is quite modest in neurons compared to its abundant expression
in astrocytes and microglia (23). Dec2 is a transcriptional repressor
and negative regulator of the molecular clock (24). Although Fabp7
circadian transcription is regulated by Nr1d1, another clock repressor
(25), it is possible that Dec2 may influence Fabp7 gene expression
through downstream transcriptional regulation on molecular clock
output genes, including Nr1d1. In addition, Fabp7 nuclear localization
may provide feedback on the clock because FABPs are known to reg-
ulate peroxisome proliferator–activated receptor (PPAR) transcription
(8), and PPARs, in turn, regulate clock genes to integrate circadian
rhythms with energy metabolism (25, 26).
Although it is conceivable that Fabp7 operates through shared
pathways with Dec2, there are other possible mechanisms that link
Fabp7 with sleep regulation. DHA supplementation has been shown
to decrease the number of night awakenings and increase sleep in chil-
dren (27), and therefore, DHA signaling may represent one possible
mechanism linking FABP7 to sleep. For example, following DHA
binding to FABP7, the NLS is normally formed with a 3D shift of
the K21 site, which is affected by the T61M mutation (Fig. 1). We
observe more sleep fragmentation in carriers of the T61M mutation
compared to WT FABP7 (Fig. 2). This suggests that FABP7 nuclear
localization mediated by DHA binding and downstream transcrip-
tional events in astrocytes may facilitate consolidated sleep. Fabp7 KO
mice show aberrant dendritic morphology with a reduction in numbers
of excitatory synapses, along with decreased synaptic transmission (28).
Hippocampal neurons acutely dissociated from Fabp7 KO mice also
show a suppression of DHA-induced N-methyl-D-aspartate currents
(29), suggesting a dysfunction in normal excitatory synaptic transmis-
sion. Although Fabp7 KO mice show increased anxiety-like phenotypeFig. 4. Overexpression of FABP7.T61M mutation in astrocytes fragments
sleep in Drosophila. Daytime (A) and nighttime (B) sleep was fragmented in flies
overexpressing FABP7.T61M compared to FABP7.WT using an astrocyte-specific
(Alrm-Gal4) driver. Total sleep, bout duration, maximum bout duration, and fre-
quency of bouts are shown. *P < 0.05, ***P < 0.001, n = 32 flies (WT) and 27 flies
(T61M). Error bars represent SEM.4 of 7
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We have shown that Fabp7mRNA and protein targeted to the fine peri-
synaptic astrocytic processes oscillate in tandem with the sleep-wake
cycle in the mouse brain (12). Therefore, it is possible that the cycling
of Fabp7 expression with sleep and wake acts to regulate synaptic events
required for normal sleep-wake behavior. o
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 MATERIALS AND METHODS
All studies followed relevant institutional review guidelines. Please see
acknowledgments for details.
Human subjects
The subjects used in this study were male employees of a wholesale
company in Osaka, Japan. Of 466 male subjects invited to partici-
pate, 322 took part in a 1-week survey, which included sleep diaries
and actigraphy. A total of 310 subjects agreed to have their genomic
DNA from blood analyzed, and data from subjects with validated
DNA sequencing were used (n = 294). Sleep-wake schedules were ob-
tained by 7-day sleep logs with coincident wrist actigraphy (Actiwatch
AW-Light, Mini-Mitter) recorded in 1-min bins as previously described
(30). Genomic DNA was extracted from leukocytes with the QIAamp
DNA Blood Mini kit (Qiagen K.K.). Genome-wide genotyping was per-
formed with Illumina HumanOmniExpress v1.0 (Illumina). Fabp7
SNP, rs2279381 data were used in this study.
Genotyping of subjects was confirmed by DNA sequencing (RIKEN
Brain Science Institute). Genotyping of FABP7 Thr61Met (rs2279381)
was carried out using the TaqMan SNP Genotyping Assays (Applied
Biosystems) (assay ID: C__15967661_20) according to themanufacturer’s
recommendations. Analysis was performed by ABI 7900HT and SDS
v2.4 software (Applied Biosystems). The accuracy of genotype based
on sequencing can be seen in our previous work (31).
Human sleep analysis
Records were scored for in Actiware 6 software (Philips Respironics)
with a wake threshold value of 40, immobile minutes for sleep onset of
10 min, and immobile minutes for sleep end of 10 min; these settings
are conservative in the context of sleep fragmentation. Subjects’ sleep
diaries were used to distinguish time-in-bed intervals from off-wrist
intervals. For each 24-hour period, the sleep interval with the longest
duration was considered the main sleep period. Analyses were performed
blind to genotype.
Animal subjects and handling
Generation of Fabp7 null (Fabp7KO)mice has been previously described
(29). Animals used in these studies were coisogenic males (C57BL/6J
background) between 2 and 5 months of age, born and maintained from
a breeding colony. Animals were entrained to a 12-hour light/12-hour
dark schedule for a minimum of 2 weeks. ZT 0 is lights on and ZT 12
is lights off.
EEG/EMG monitoring and analysis
Surgery for EEG/EMG (electromyography) recording and data acqui-
sition and analysis were performed as previously described (32, 33).
Briefly, EEG/EMG headmounts were manually constructed and im-
planted onto mice anesthetized with ketamine (100 mg/kg) and xylene
(10 mg/kg). Silver ball electrodes were pushed into holes drilled above
the frontal and parietal brain areas, and the headmount was secured
with dental cement.After 1-week recovery,micewere tethered to recordingGerstner et al., Sci. Adv. 2017;3 : e1602663 5 April 2017cables and allowed an additional week of acclimation. Undisturbed sleep/
wake (24 hours) was recorded, followed the next day by 6 hours of sleep
deprivation (ZT 0 to ZT 6) and recovery (ZT 6 to ZT 24). Polysomno-
graphic recordings were segmented into 4-s epochs and manually scored
as one of three behavioral states: wake, NREM sleep, or REM sleep.
Cumulative NREM delta power (34, 35) was computed for each 1-hour
bin and normalized to the average NREM delta power during ZT 8 to
ZT 12 (17) of the undisturbed recording day. Analyses were repeated with
normalization to NREM delta power during the whole 24-hour, un-
disturbed recording day (results were equivalent). Normalization factors
were not significantly different betweenFabp7KOandWTmice (P>0.05).
Running wheel activity monitoring and analysis
Diurnal activity analysis was obtained using running wheels and
running wheel analysis software (Med Associates). Briefly, wireless
running wheels were placed in normal cages, and mice were allowed
ad libitum access to runningwheels under a 12-hour light/12-hour dark
cycle for 10 days. On the 10th day, revolutions were counted and com-
pared between Fabp7 KO and WT mice in hourly and 12-hour bins.
Cloning FABP7
TheFABP7WTopen reading frame andFABP7 c/tmutation (at position
182 to generate T61M missense mutation from ATG start site codon)
complementary DNAwere ordered fromGeneART (Life Technologies);
primers on the 5′ containing Eco RI and 3′ containing Bgl II restriction
site (underlined, in yellow highlight, respectively) were as follows:
hFABP7 5′-full_EcoR1_24: accaccgaattccaacatggtggaggctttctgtgctacc
hFABP7 3′-full_BglII_30: accaccagatcttctttatgccttctcatagtggcgaacagcaac
These were polymerase chain reaction–amplified, TA-cloned, sub-
cloned into pUAST vector, and confirmed by DNA sequencing (see se-
quences below). Transgenic flies were made by injecting Drosophila
embryos in the w (isoCJ1) isogenic background (BestGene).
hFABP7: accaccgaattccaacatggtggaggctttctgtgctacctggaagctgaccaacagtca-
gaactttgatgagtacatgaaggctctaggcgtgggctttgccactaggcaggtgggaaatgtgac-
caaaccaacggtaattatcagtcaagaaggagacaaagtggtcatcaggactctcagcacattcaa-
gaacacggagattagtttccagctgggagaagagtttgatgaaaccactgcagatgatagaaactgt-
aagtctgttgttagcctggatggagacaaacttgttcacatacagaaatgggatggcaaagaaa-
caaattttgtaagagaaattaaggatggcaaaatggttatgacccttacttttggtgatgtggttgctgttcgcc-
actatgagaaggcataaagaagatctggtggt
hFABP7 c/t mt (Thr61Met): accaccgaattccaacatggtggaggctttctgtgctacct-
ggaagctgaccaacagtcagaactttgatgagtacatgaaggctctaggcgtgggctttgccactagg-
caggtgggaaatgtgaccaaaccaacggtaattatcagtcaagaaggagacaaagtggtcatcag-
gactctcagcacattcaagaacat ggagattagtttccagctgggagaagagtttgatgaaaccactgca-
gatgatagaaactgtaagtctgttgttagcctggatggagacaaacttgttcacatacagaaatgg-
gatggcaaagaaacaaattttgtaagagaaattaaggatggcaaaatggttatgacccttacttttggt-
gatgtggttgctgttcgccactatgagaaggcataaagaagatctggtggt
Protein modeling
The FABP7WT and T61M protein structure modeling was carried out
using SWISS-MODEL (https://swissmodel.expasy.org/) (36).
Drosophila sleep analysis
Transgenic flies in the w (isoCJ1) isogenic background were maintained
on standard yeast-cornmeal food at 25°C and entrained to a 12-hour
light/12-hour dark cycle for 2 to 3 days before they were assayed for sleep.
For analysis of sleep behavior, ~6-day-old female and male flies were as-
sayed using the Drosophila Activity Monitoring System (TriKinetics),
carried out as previously described (37). Drosophila glial-GeneSwitch
Gal4 driver lines were obtained from the Bloomington Stock Center.5 of 7
SC I ENCE ADVANCES | R E S EARCH ART I C L EGeneSwitch experiments were carried out as previously described (38).
Briefly, inducible expression of downstream UAS-transgenic lines was
obtained by adding 500 mMRU486 (mifepristone, dissolved in 80% eth-
anol) in 2% agar and 5% sucrose minimal medium. Flies were first re-
corded in tubes containing only 2% agar and 5% sucrose minimal
medium with vehicle and, after 4 days, were switched to minimal me-
dium containing drug for the duration of the recording.
Statistical analyses
Group comparisons were made using Student’s t test or, in the case of
unequal sample sizes, Welch’s t test. Where multiple comparisons were
required, we used repeated-measures ANOVA with factors for compar-
ison as indicated. Significant differences were P < 0.05, unless indi-
cated otherwise.http://advances.scienc
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 SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/3/4/e1602663/DC1
table S1. Age, body mass index, and sleepiness comparison between FABP7.T61M carriers and
noncarriers.
table S2. Health status comparison between FABP7.T61M carriers and noncarriers.
fig. S1. Baseline total sleep-wake time is not affected in Fabp7 KO mice.
fig. S2. Locomotor running wheel activity is not affected in Fabp7 KO mice.
fig. S3. REM sleep time is increased in Fabp7 KO mice during the recovery period following
sleep deprivation.
fig. S4. Overexpression of FABP7.T61M mutation in astrocytes fragments wake only during the
daytime in Drosophila.
fig. S5. Overexpression of FABP7.T61M mutation in astrocytes in male flies also fragments
sleep.
fig. S6. Overexpression of FABP7.T61M mutation in astrocytes in male flies also fragments
wake.
fig. S7. Conditional overexpression of FABP7.T61M mutation in glial cells of adult male flies also
fragments sleep in Drosophila. o
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table S1. Age, body mass index, and sleepiness comparison between FABP7.T61M 
carriers and noncarriers. BMI: Body Mass Index; ESS: Epworth Sleepiness Scale. Values 
are ± SEM.  
 
Genotype Age BMI ESS 
hFabp7.wt 43.4 ± 0.5 24.0 ± 0.2 6.5 ± 0.2 
hFabp7.T61M 45.1 ± 1.5 23.8 ± 0.5 7.1 ± 0.6 
 
 
 
 
table S2. Health status comparison between FABP7.T61M carriers and noncarriers. 
Results for Short Form 36 Health Survey: VT (Vitality), PF (Physical Functioning), BP 
(Bodily Pain), GH (General Health), PR (Physical Role), ER (Emotional Role), SR (Social 
Role), MH (Mental Health); and for Zung Self-rating Depression Scale (SDS). **P < 0.01. 
Values are ± SEM.  
 
Genotype VT PF BP GH PR 
hFabp7.wt 50.6 ±- 0.5 54.0 ± 0.4 51.7 ± 0.6 51.4 ± 0.6 52.5 ± 0.4 
hFabp7.T61M 47.9 ± 1.8 51.5 ± 1.3 48.7 ± 1.6 48.7 ± 1.6 51.9 ± 1.8 
      
Genotype ER SR MH SDS 
hFabp7.wt 51.9 ± 0.5 52.8 ± 0.5 50.7 ± 0.6 36.4 ± 0.4 
hFabp7.T61M 49.7 ± 1.9 51.7 ± 1.3 50.6 ± 1.5 39.9 ± 1.1** 
 
 
 
 
fig. S1. Baseline total sleep-wake time is not affected in Fabp7 KO mice. Baseline wake 
time (A), NREM time (B), and REM time (C) in Fabp7 KO mice (n = 8) compared to WT 
littermates (n = 7) shows no significant difference when binned into light period (ZT 0–12) 
and dark period (ZT 12–24). Error bars represent SEM. 
 
 fig. S2. Locomotor running wheel activity is not affected in Fabp7 KO mice. Diurnal 
hourly running wheel activity (A), and total revolutions show no significant differences when 
binned into the light period (B, ZT0-12) or in the dark period (C, ZT12-24) in Fabp7 KO 
mice (n = 8) compared to WT littermates (n = 8). Error bars represent SEM. 
 
 
 
 
 
fig. S3. REM sleep time is increased in Fabp7 KO mice during the recovery period 
following sleep deprivation. Wake time during the immediate recovery period (A, ZT 7–12) 
or in the subsequent dark period (B, ZT 13–24) following 6 hours of sleep deprivation is 
similar between Fabp7 KO mice (n = 8) and WT littermates (n = 7). NREM sleep time is 
unaffected in the immediate recovery period (C) and subsequent dark period (D). REM sleep 
time is unaffected by Fabp7 deficiency compared to WT in the immediate recovery period 
(E), but is significantly increased during the subsequent dark period (F). *P < 0.05. Error 
bars represent SEM. 
 
 
 
 
fig. S4. Overexpression of FABP7.T61M mutation in astrocytes fragments wake only 
during the daytime in Drosophila. Daytime (A) but not nighttime (B) wake was fragmented 
in female flies overexpressing FABP7.T61M compared to FABP7.WT using an astrocyte-
specific (Alrm-Gal4) driver. Total wake, bout duration, maximum bout duration, and 
frequency of bouts are shown. *P < 0.05, **P < 0.01, ***P < 0.001, n = 32 flies (WT), n = 
27 flies (T61M). Error bars represent SEM. 
 
 
 
 
fig. S5. Overexpression of FABP7.T61M mutation in astrocytes in male flies also 
fragments sleep. Daytime (A) and nighttime (B) sleep was reduced, while nighttime sleep 
was fragmented, in male flies overexpressing FABP7.T61M compared to FABP7.WT using 
an astrocyte-specific (Alrm-Gal4) driver. Total sleep, bout duration, maximum bout duration, 
and frequency of bouts are shown. *P < 0.05, **P < 0.01, ***P < 0.001, n = 32 flies (WT),    
n = 27 flies (T61M). Error bars represent SEM. 
 
 
 
fig. S6. Overexpression of FABP7.T61M mutation in astrocytes in male flies also 
fragments wake. Daytime (A) and nighttime (B) wake was fragmented in male flies 
overexpressing FABP7.T61M compared to FABP7.WT using an astrocyte-specific (Alrm-
Gal4) driver. Total wake, bout duration, maximum bout duration, and frequency of bouts are 
shown. *P < 0.05, ***P < 0.001, n = 11 flies per group. Error bars represent SEM. 
 
 fig. S7. Conditional overexpression of FABP7.T61M mutation in glial cells of adult male 
flies also fragments sleep in Drosophila. Flies treated with vehicle (A), RU486 for 1 day 
(B), and RU486 for 4 days (C) show sleep was fragmented in FABP7.T61M compared to 
FABP7.WT using a Glial-GeneSwitch-Gal4 driver. Night-time total sleep, bout duration, 
maximum bout duration, and frequency of bouts are shown. *P < 0.05, **P < 0.01, n = 15 
flies (WT), n = 13 flies (T61M). Error bars represent SEM. 
